Source 1primary paper2025MED
Toolkit/GI norovirus VP1 virus-like particles
GI norovirus VP1 virus-like particles
Also known as: GI NoV VLPs, Norovirus Virus-like particles (VLPs)
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
NoV Virus-like particles (VLPs) composed of the major capsid protein VP1 (~60 kDa) are essential for vaccine development... VP1 from four epidemiologically relevant GI genotypes was expressed using the silkworm-baculovirus system.
Usefulness & Problems
Why this is useful
These VP1-based GI norovirus VLPs provide noninfectious particle material for structural, stability, and functional epitope characterization. The study uses them to compare four epidemiologically relevant GI genotypes.; vaccine development; genotype-specific structural characterization; stability profiling across GI norovirus genotypes; functional epitope assessment via HBGA-mimic binding
Source:
These VP1-based GI norovirus VLPs provide noninfectious particle material for structural, stability, and functional epitope characterization. The study uses them to compare four epidemiologically relevant GI genotypes.
Source:
vaccine development
Source:
genotype-specific structural characterization
Source:
stability profiling across GI norovirus genotypes
Source:
functional epitope assessment via HBGA-mimic binding
Problem solved
They address the poor characterization of GI norovirus VLPs by enabling genotype-specific purification, structural analysis, and stability profiling relevant to vaccine design.; provides GI genotype-resolved VLP material for purification, structural analysis, and stability testing
Source:
They address the poor characterization of GI norovirus VLPs by enabling genotype-specific purification, structural analysis, and stability profiling relevant to vaccine design.
Source:
provides GI genotype-resolved VLP material for purification, structural analysis, and stability testing
Problem links
provides GI genotype-resolved VLP material for purification, structural analysis, and stability testing
LiteratureThey address the poor characterization of GI norovirus VLPs by enabling genotype-specific purification, structural analysis, and stability profiling relevant to vaccine design.
Source:
They address the poor characterization of GI norovirus VLPs by enabling genotype-specific purification, structural analysis, and stability profiling relevant to vaccine design.
Published Workflows
Objective: Produce and characterize GI norovirus VP1-derived VLPs from four epidemiologically relevant genotypes, define genotype-specific purification and stability constraints, and generate data relevant to multivalent vaccine design.
Why it works: The workflow combines expression and genotype-specific purification with orthogonal structural, size-distribution, thermal-stability, and functional-binding assays to define whether GI VP1 forms VLPs that remain structurally intact and epitope competent under different conditions.
VLP assembly from VP1retention of HBGA-binding functional epitopesgenotype-dependent structural stabilitysilkworm-baculovirus expressiongenotype-specific purification optimizationSECDLSTEMDSFHBGA-mimic binding assay
Stages
- 1.Expression of GI VP1 constructs in silkworm-baculovirus system(library_build)
This stage creates the genotype-specific VP1 particle material needed for purification and all downstream analyses.
Selection: Generate VP1-derived material from four epidemiologically relevant GI genotypes for downstream purification and characterization.
- 2.Genotype-specific purification optimization(secondary_characterization)
Purification is needed before structural, stability, and functional analyses, and the abstract states that conditions differed by genotype.
Selection: Optimize purification conditions in a genotype-specific manner.
- 3.Orthogonal structural and biophysical characterization(functional_characterization)
This stage establishes structural and biophysical profiles of the purified GI VLPs.
Selection: Analyze purified VLPs using SEC, DLS, TEM, and DSF.
- 4.Functional epitope confirmation by HBGA-mimic binding(confirmatory_validation)
After structural characterization, the study confirms that purified particles still present functional epitopes.
Selection: Confirm functional epitopes via binding to HBGA mimics.
- 5.Stability assessment across pH and temperature conditions(secondary_characterization)
This stage identifies genotype-specific stability constraints that directly inform design and formulation of multivalent vaccines.
Selection: Assess genotype-dependent pH and thermal tolerance including aggregation and structural transitions.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Mechanisms
aggregation under destabilizing conditionsglycan ligand binding via retained hbga-recognizing epitopesself-assembly of vp1 into virus-like particlesthermal and ph-dependent structural transitionTarget processes
No target processes tagged yet.
Input: Thermal
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: actuator
The abstract supports a silkworm-baculovirus expression system plus genotype-specific purification and downstream SEC, DLS, TEM, DSF, and HBGA-mimic binding assays.; requires VP1 expression in the silkworm-baculovirus system; requires genotype-specific purification optimization; requires SEC, DLS, TEM, DSF, and HBGA-mimic binding analyses for characterization
The abstract does not show that these VLPs alone solve formulation, immunogenicity, or clinical protection questions. It also indicates that stability constraints remain genotype specific.; GI VLPs were previously poorly characterized; stability is genotype dependent with differences in pH and thermal tolerance including aggregation and structural transitions
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
The study defines genotype-specific purification, structural characterization, and stability profiles for four GI norovirus VLPs and provides a systematic framework relevant to multivalent vaccine design.
The purified GI norovirus VLPs retained functional epitopes as confirmed by binding to HBGA mimics.
VP1 from four epidemiologically relevant GI norovirus genotypes was expressed in the silkworm-baculovirus system and yielded purified VLPs that were structurally and biophysically characterized.
The GI norovirus VLPs showed genotype-dependent differences in pH and thermal tolerance, including aggregation and structural transitions.
Approval Evidence
1 source4 linked approval claimsfirst-pass slug gi-norovirus-vp1-virus-like-particles
NoV Virus-like particles (VLPs) composed of the major capsid protein VP1 (~60 kDa) are essential for vaccine development... VP1 from four epidemiologically relevant GI genotypes was expressed using the silkworm-baculovirus system.
Source:
framework contributionsupports
The study defines genotype-specific purification, structural characterization, and stability profiles for four GI norovirus VLPs and provides a systematic framework relevant to multivalent vaccine design.
Source:
functional epitope validationsupports
The purified GI norovirus VLPs retained functional epitopes as confirmed by binding to HBGA mimics.
Source:
production and characterizationsupports
VP1 from four epidemiologically relevant GI norovirus genotypes was expressed in the silkworm-baculovirus system and yielded purified VLPs that were structurally and biophysically characterized.
Source:
stability differencesupports
The GI norovirus VLPs showed genotype-dependent differences in pH and thermal tolerance, including aggregation and structural transitions.
Source:
Comparisons
Source-stated alternatives
The source contrasts GI and GII as major norovirus genogroups and notes GI VLPs are less characterized, but it does not name a specific alternative VLP platform within the abstract.
Source:
The source contrasts GI and GII as major norovirus genogroups and notes GI VLPs are less characterized, but it does not name a specific alternative VLP platform within the abstract.
Source-backed strengths
supports structural and stability comparison across four GI genotypes; retains functional epitopes as assessed by HBGA-mimic binding
Source:
supports structural and stability comparison across four GI genotypes
Source:
retains functional epitopes as assessed by HBGA-mimic binding
Compared with dengue enveloped viral-like particle vaccine prototype
The source contrasts GI and GII as major norovirus genogroups and notes GI VLPs are less characterized, but it does not name a specific alternative VLP platform within the abstract.
Shared frame: source-stated alternative in extracted literature
Strengths here: supports structural and stability comparison across four GI genotypes; retains functional epitopes as assessed by HBGA-mimic binding.
Relative tradeoffs: GI VLPs were previously poorly characterized; stability is genotype dependent with differences in pH and thermal tolerance including aggregation and structural transitions.
Source:
The source contrasts GI and GII as major norovirus genogroups and notes GI VLPs are less characterized, but it does not name a specific alternative VLP platform within the abstract.
Compared with HIV-1 Gag-based virus-like particles
The source contrasts GI and GII as major norovirus genogroups and notes GI VLPs are less characterized, but it does not name a specific alternative VLP platform within the abstract.
Shared frame: source-stated alternative in extracted literature
Strengths here: supports structural and stability comparison across four GI genotypes; retains functional epitopes as assessed by HBGA-mimic binding.
Relative tradeoffs: GI VLPs were previously poorly characterized; stability is genotype dependent with differences in pH and thermal tolerance including aggregation and structural transitions.
Source:
The source contrasts GI and GII as major norovirus genogroups and notes GI VLPs are less characterized, but it does not name a specific alternative VLP platform within the abstract.
Compared with virus-like particles
The source contrasts GI and GII as major norovirus genogroups and notes GI VLPs are less characterized, but it does not name a specific alternative VLP platform within the abstract.
Shared frame: source-stated alternative in extracted literature
Strengths here: supports structural and stability comparison across four GI genotypes; retains functional epitopes as assessed by HBGA-mimic binding.
Relative tradeoffs: GI VLPs were previously poorly characterized; stability is genotype dependent with differences in pH and thermal tolerance including aggregation and structural transitions.
Source:
The source contrasts GI and GII as major norovirus genogroups and notes GI VLPs are less characterized, but it does not name a specific alternative VLP platform within the abstract.
Ranked Citations
- 1.